Why the study?
Does propranolol affect plasma ANP levels and hemodynamics in outpatients with essential hypertension?
Does propranolol affect plasma ANP levels and hemodynamics in outpatients with essential hypertension?
Answers are grounded in this paper and cite their sources.
Propranolol treatment in essential hypertension increases plasma ANP levels, which correlates with its antihypertensive effect but also reduces cardiac index.
The effects of beta-blocker treatment on hemodynamics were studied in relation to plasma atrial natriuretic peptide (ANP) levels in 17 outpatients with essential hypertension. Administration of propranolol for twelve weeks to untreated subjects resulted in a significant (P < 0.001) rise in plasma ANP levels (from 37.9 +/- 21.2 to 66.7 +/- 46.2 pg/mL, mean +/- SD). Systolic and diastolic blood pressures were significantly decreased (P < 0.05 and P < 0.01, respectively). Heart rate was also significantly decreased (P < 0.001). On the other hand, a significant reduction of cardiac index was detected (from 4.12 +/- 1.34 to 2.96 +/- 0.75 L/min/m2, P < 0.01) with chronic administration of propranolol, suggesting a reflection of decreased cardiac function. A significant negative correlation was observed between %changes in systolic blood pressure and %changes in plasma ANP (r = -0.594, P < 0.05). These results suggest that the increased plasma ANP levels may contribute to the antihypertensive effect with propranolol.
No takes yet. Share an insight, caveat, or question.
Hama et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: